Literature DB >> 15004438

Matrix metalloproteinases of human leiomyoma in various stages of tumor growth.

Małgorzata Wolańska1, Krzysztof Sobolewski, Edward Bańkowski, Stefan Jaworski.   

Abstract

The amounts and activities of matrix metalloproteinases (MMPs) were studied in human myometrium and uterine leiomyomas in various stages of growth. It was found that both myometrium and the investigated tumors contain collagenolytic enzymes. MMP-1, MMP-2, MMP-3 and MMP-9 were found. Gelatinase A (MMP-2) is the most abundant. In control myometrium only 10% of this enzyme exists in an active form, whereas in tumors, especially in large ones, the values reach 30%. It is suggested that the high activity of MMP-2 is responsible for remodelling of extracellular matrix in the growing tumors. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004438     DOI: 10.1159/000077177

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  13 in total

1.  A nongenomic mechanism for "metalloestrogenic" effects of cadmium in human uterine leiomyoma cells through G protein-coupled estrogen receptor.

Authors:  Jingli Liu; Linda Yu; Lysandra Castro; Yitang Yan; Maria I Sifre; Carl D Bortner; Darlene Dixon
Journal:  Arch Toxicol       Date:  2019-08-29       Impact factor: 5.153

2.  Matrix production and remodeling as therapeutic targets for uterine leiomyoma.

Authors:  Caitlin Fujisawa; John J Castellot
Journal:  J Cell Commun Signal       Date:  2014-07-11       Impact factor: 5.782

3.  Fibroid-associated heavy menstrual bleeding: correlation between clinical features, Doppler ultrasound assessment of vasculature, and tissue gene expression profiles.

Authors:  Sophia E Tsiligiannis; Marina Zaitseva; Peter R Coombs; Paul Shekleton; Moshe Olshansky; Martha Hickey; Beverley Vollenhoven; Peter A W Rogers
Journal:  Reprod Sci       Date:  2012-09-20       Impact factor: 3.060

4.  Ulipristal Acetate and Extracellular Matrix Production in Human Leiomyomas In Vivo: A Laboratory Analysis of a Randomized Placebo Controlled Trial.

Authors:  Jeris Cox; Minnie Malik; Joy Britten; Terrence Lewis; William H Catherino
Journal:  Reprod Sci       Date:  2017-09-20       Impact factor: 3.060

Review 5.  Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder.

Authors:  Nasser Chegini
Journal:  Semin Reprod Med       Date:  2010-04-22       Impact factor: 1.303

Review 6.  A Systematic Review of Vitamin D and Fibroids: Pathophysiology, Prevention, and Treatment.

Authors:  Abigail Combs; Bhuchitra Singh; Elisabeth Nylander; Md Soriful Islam; Ha Vi Nguyen; Elissa Parra; Ameerah Bello; James Segars
Journal:  Reprod Sci       Date:  2022-08-12       Impact factor: 2.924

7.  Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells.

Authors:  Sunil K Halder; Kevin G Osteen; Ayman Al-Hendy
Journal:  Hum Reprod       Date:  2013-06-27       Impact factor: 6.918

8.  Relaxin increases elastase activity and protease inhibitors in smooth muscle cells from the myometrium compared with cells from leiomyomas.

Authors:  Bertha Chen; Yan Wen; Xiao Yun Yu; Mary Lake Polan
Journal:  Fertil Steril       Date:  2008-06-12       Impact factor: 7.329

Review 9.  Macrophages and Immune Responses in Uterine Fibroids.

Authors:  Alessandro Zannotti; Stefania Greco; Pamela Pellegrino; Federica Giantomassi; Giovanni Delli Carpini; Gaia Goteri; Andrea Ciavattini; Pasquapina Ciarmela
Journal:  Cells       Date:  2021-04-22       Impact factor: 6.600

10.  Retinoic acid treatment of human leiomyoma cells transformed the cell phenotype to one strongly resembling myometrial cells.

Authors:  Minnie Malik; Joy Webb; William H Catherino
Journal:  Clin Endocrinol (Oxf)       Date:  2008-02-01       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.